Literature DB >> 24606201

Can pluripotent stem cells be used in cell-based therapy?

Virginia Picanço-Castro1, Lilian F Moreira, Simone Kashima, Dimas T Covas.   

Abstract

Pluripotent stem cells, both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), have the ability to differentiate into several cell types that can be used in drug testing and also in the study and treatment of diseases. These cells can be differentiated by in vitro systems, which may serve as models for human diseases and for cell transplantation. In this review, we address the pluripotent cell types, how to obtain and characterize these cells, and differentiation assays. We also focus on the potential of these cells in clinical trials, and we describe the clinical trials that are underway.

Entities:  

Mesh:

Year:  2014        PMID: 24606201      PMCID: PMC3967385          DOI: 10.1089/cell.2013.0072

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  66 in total

1.  Human embryonic stem cells express an immunogenic nonhuman sialic acid.

Authors:  Maria J Martin; Alysson Muotri; Fred Gage; Ajit Varki
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

2.  Dopaminergic differentiation of human embryonic stem cells.

Authors:  Xianmin Zeng; Jingli Cai; Jia Chen; Yongquan Luo; Zhi-Bing You; Erin Fotter; Yun Wang; Brandon Harvey; Takumi Miura; Cristina Backman; Guann-Juh Chen; Mahendra S Rao; William J Freed
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  Human embryonic germ cells isolation from early stages of post-implantation embryos.

Authors:  ShanRong Liu; HouQi Liu; YuQiong Pan; ShuPing Tang; Jun Xiong; Ning Hui; ShuLing Wang; ZhongTian Qi; LingSong Li
Journal:  Cell Tissue Res       Date:  2004-10-02       Impact factor: 5.249

4.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

Authors:  G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

5.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

6.  Generation of hepatocyte-like cells from human embryonic stem cells.

Authors:  Lakshmi Rambhatla; Choy-Pik Chiu; Pratima Kundu; Yun Peng; Melissa K Carpenter
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

7.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

8.  Differentiation of human embryonic stem cells into insulin-producing clusters.

Authors:  Hanna Segev; Bettina Fishman; Anna Ziskind; Margarita Shulman; Joseph Itskovitz-Eldor
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

9.  Isolation and culture of inner cell mass cells from human blastocysts.

Authors:  A Bongso; C Y Fong; S C Ng; S Ratnam
Journal:  Hum Reprod       Date:  1994-11       Impact factor: 6.918

10.  Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon.

Authors:  Kosuke Yusa; Roland Rad; Junji Takeda; Allan Bradley
Journal:  Nat Methods       Date:  2009-03-31       Impact factor: 28.547

View more
  5 in total

Review 1.  Towards translational optogenetics.

Authors:  Akshaya Bansal; Swati Shikha; Yong Zhang
Journal:  Nat Biomed Eng       Date:  2022-01-13       Impact factor: 29.234

Review 2.  Advancing stem cell therapy from bench to bedside: lessons from drug therapies.

Authors:  Thekkeparambil Chandrabose Srijaya; Thamil Selvee Ramasamy; Noor Hayaty Abu Kasim
Journal:  J Transl Med       Date:  2014-09-04       Impact factor: 5.531

3.  Delayed Mesoderm and Erythroid Differentiation of Murine Embryonic Stem Cells in the Absence of the Transcriptional Regulator FUBP1.

Authors:  Josephine Wesely; Marlene Steiner; Frank Schnütgen; Manuel Kaulich; Michael A Rieger; Martin Zörnig
Journal:  Stem Cells Int       Date:  2017-05-15       Impact factor: 5.443

Review 4.  May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.

Authors:  Nicholas Brookhouser; Sreedevi Raman; Christopher Potts; David A Brafman
Journal:  Cells       Date:  2017-02-06       Impact factor: 6.600

5.  Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy.

Authors:  Guilherme Visconde Brasil; Danúbia Silva Dos Santos; Elias Ataide Mendonça; Fernanda Cristina Paccola Mesquita; Tais Hanae Kasai-Brunswick; Sandro Torrentes da Cunha; Cibele Ferreira Pimentel; Andréia de Vasconcelos-Dos-Santos; Rosália Mendez-Otero; Clério Francisco de Azevedo Filho; Regina Coeli Dos Santos Goldenberg; Antonio Carlos Campos de Carvalho
Journal:  Cells       Date:  2020-07-07       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.